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Abstract
Background. A low health-related quality of life (HQL)
is associated with the evolution of chronic kidney disease
(CKD) and mortality in patients in end-stage of the
disease. Therefore research on psychological determinants
of HQL is emerging. We investigate whether acceptance
of the disease contributes to a better physical and mental
health-related quality of life (PHQL and MHQL). We also
examine the impact of personality characteristics on ac-
ceptance, PHQL and MHQL.
Methods. In this cross-sectional study, patients from an
outpatient clinic of nephrology completed self-report
questionnaires on quality of life, acceptance and personal-
ity characteristics. We performed correlations, regression
analyses and a path analysis.
Results. Our sample of 99 patients had a mean duration of
CKD of 10.81 years and a mean estimated Glomerular Fil-
tration Rate (eGFR) by Modiﬁcation of Diet in Renal
Disease (MDRD)-formula of 34.49 ml/min (SD 21.66).
Regression analyses revealed that acceptance had a signiﬁ-
cant positive contribution to the prediction of PHQL and
MHQL. Neuroticism was negatively associated with accep-
tance and MHQL. Path analysis showed that 37% of the
total effect of neuroticism on MHQL was mediated by ac-
ceptance.
Conclusions. Acceptance is an important positive variable
in accounting for HQL, however, clinicians must be aware
that if patients have a high level of neuroticism they are
likely to have more difﬁculties with this coping strategy.
These results provide a better understanding of psychological
determinants of HQL in CKD, which can initiate another ap-
proach of these patients by nephrologists, speciﬁc psycho-
logical interventions, or other supporting public health
services.
Keywords: acceptance; chronic kidney disease; health-related quality of
life; neuroticism; personality characteristics
Introduction
Chronic kidney disease (CKD) is a major health problem
worldwide, with a prevalence that increases with age [1]
and with a signiﬁcant negative effect on the health-related
quality of life (HQL). HQL is associated with risk of evol-
ution to end-stage kidney disease and increased mortality in
those end-stage patients [2–4]. Because of its high impact,
research on HQL in CKD has increased over the years. Re-
ported satisfaction of haemodialysis patients with their per-
sonal health is positively correlated with HQL. Negative
mental health, e.g. depression, high psychological distress
and psychiatric disorders, all of which are prevalent amongst
CKD patients, is a negative predictor of HQL in CKD [5–
17]. Folkman and Greer [18] suggested that in addition to a
symptom-orientated approach to general chronic illness,
there should be more focus on achieving psychological well-
being. We have focussed our study on ‘acceptance’ as a
possible positive predictor of well-being or HQL.
Accommodative coping has been described as appropri-
ate for a good psychological adjustment to unchangeable
events [19, 20] and is commonly deﬁned as ‘adjusting pre-
ferences and goals in line with experienced constraints and
limitations’, e.g. because of chronic disease. Within this
coping strategy, acceptance is considered a key variable.
When patients accept the disease, it is assumed that they
will adjust their life goals towards more achievable goals
by integrating this difﬁcult life event [19, 21]. Chronic dis-
eases are seen as life events, which upset a person’s
emotional balance, and acceptance is crucial establishing a
new balance. When patients with chronic pain and chronic
fatigue refuse to accept their medical situation and use an
assimilative coping strategy, which is characterized by per-
sisting in attempts to seek a cure for the medical problem,
at the cost of other valued life goals, they report more cata-
strophizing and a lower mental HQL (MHQL) [22–25].
Also in cardiac patients [26], acceptance positively predicts
physical functioning and mental well-being, whereas help-
lessness has a negative inﬂuence. For CKD, type of coping
strategy is associated with compliance [27], and in patients
with end-stage renal disease, there is evidence that avoidant
coping is related to mortality [28]. The ﬁve-factor model of
personality has been frequently used in research exploring
the relationship between personality and coping [29–38].
The personality characteristics of the Big Five Personality
model are: neuroticism, extraversion, openness,
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agreeableness and conscientiousness. For CKD, it has been
found that conscientiousness is associated with better com-
pliance with prescribed medication [27] and neuroticism is
related to outcome measures such as perceived mental
health, psychosocial adjustment and coping [32, 39, 40].
Neuroticism also appears to be associated with a wide
range of disorders of physical health, including kidney
disease [41]. However, little is known about the role that
personality characteristics have on acceptance.
This study in a CKD population evaluates (i) whether
acceptance is associated with a better health quality of
life, both physical (PHQL) and mental (MHQL) and (ii)
whether personality characteristics inﬂuence acceptance
and HQL (PHQL and MHQL), even after controlling for
some putative confounding variables. We further hypoth-
esize that the personality characteristic neuroticism has a
negative inﬂuence on acceptance, important for a good
MHQL.
Materials and methods
Study design
We performed a cross-sectional questionnaire study on the following
variables: acceptance, personality characteristics and PHQL and MHQL.
We included demographic, disease and co-morbidity variables in our
analyses to check for putative confounding effects.
Setting and participants
Data collection was performed in the outpatient clinic of the Nephrology
department of the Ghent University Hospital, from January 2009 to
August 2010. It was a consecutive recruitment in which patients were
invited during an information session by a nurse to participate in the
questionnaire study, after their visit to the nephrologist. All patients
signed an informed consent form that was approved by the local ethics
committee of the Ghent University Hospital.
Inclusion criteria of the study were as followed: knowledge of Dutch
language, age >18 years and the diagnosis of CKD.
Measurements
We used self-report questionnaires to assess the following variables:
HQL (SF-36), acceptance [Illness cognition questionnaire (ICQ)] and
personality [NEO-Five Factor Inventory (NEO-FFI)]. All participants
completed the questionnaires described below.
Short form health survey (SF-36) [42]. The SF-36 includes 36 items in
eight subscales, assessing a general HQL. There is a physical and mental
health component (PHQL and MHQL) in addition to the general health
quality score (HQL). The items were scored on a 2- to 6-point scale,
transformed in scale values from ‘0–100’. The SF-36 has been proven to
be a reliable and valid instrument to assess HQL. In our sample, the
Cronbach’s alpha coefﬁcients for the PHQL (0.88) and MHQL (0.87) are
in line with other studies, which show Cronbach’s alpha coefﬁcients of
0.90 for these summary scores [42].
Illness cognition questionnaire [43]. ‘Accommodative coping’ is a cen-
tral variable in our study and was operationalized by the subscale accep-
tance of the Dutch version of the ICQ. For our analyses, we only used
the acceptance subscale of the ICQ. This questionnaire (18 items) con-
sists of three subscales (each 6 items): acceptance (e.g. ‘I have learned to
accept the disability of my disease’), ‘helplessness’ and ‘disease
beneﬁts’. Items were scored on a 4-point scale with a range from 1 to 4
with a maximum score of 24. The Dutch version of the ICQ is con-
sidered a reliable and valid instrument, reporting Cronbach’s alpha of
0.90 for the acceptance subscale [43]. In our sample, the Cronbach’s
alpha coefﬁcient is 0.88.
NEO-Five Factor Inventory [44]. ‘Personality characteristics’ were
measured by the Dutch version of the revised NEO-FFI Personality In-
ventory based on the Big Five Personality model. This 60-item question-
naire measures ﬁve personality characteristics (each characteristic 12
items) of the Big Five Personality model: neuroticism, extraversion,
openness, agreeableness and conscientiousness. Items were scored on a
4-point scale (from ‘0 = totally not agree’ to ‘4 = totally agree’). Research
has shown that the NEO-FFI is sufﬁciently reliable (alpha coefﬁcients
vary between 0.68 and 0.86) [44]. The Cronbach’s alpha coefﬁcient in
our sample is 0.76. Also, the construct and concurrent validity has been
well documented.
Statistical methods
Missing data were most often due to missing information in medical ﬁles
and insufﬁcient responses of the participants. Data were analysed with
SPSS version 12.0 and AMOS (SPSS, Inc., Chicago, IL).
Correlation analyses were performed. We focussed on the relations
between the studied psychological variables (acceptance and personality
characteristics) and PHQL and MHQL.
Next, we performed a series of regression analyses. In two regression
analyses, we investigated the unique value of acceptance in explaining
physical and mental well-being. In both analyses, age and gender were
entered ﬁrst into the regression. Next, the disease characteristics (duration
of the disease, severity: eGFR by MDRD, dialysis condition, transplant
condition) and comorbidity characteristics (presence of polycystic kidney
disease, glomerulonephritis, diabetes mellitus, arterial hypertension, cardio-
vascular problems, stroke) were entered using a stepwise including
method. In a last block, acceptance and the personality dimensions (neur-
oticism, extraversion, openness, agreeableness and conscientiousness) were
entered using a stepwise inclusion method.
A third regression analysis (acceptance as dependent variable) was
performed to investigate the role of personality variables in explaining
acceptance. In this regression analyses, the personality variables were
entered via the stepwise inclusion method.
Finally we did a path analysis (structural equation model), in
which we took also the relation between PHQL and MHQL into
account [45, 46]. The path analysis was estimated and tested with the
maximum likelihood algorithm, which is known to be asymptotically
efﬁcient and to give correct chi-square estimators if there is not too
much multivariate kurtosis. The indices used in the path analysis for
goodness-of-ﬁt modelling were chi-square and its related degrees of
freedom (df ), probability (P), goodness-of-ﬁt index (GFI), adjusted GFI
(AGFI), comparative ﬁt index (CFI), root mean square error of approxi-
mation (RMSEA) and the Consistent Akaike Information Criterion
(CAIC). Chi-square assesses whether a signiﬁcant amount of observed
covariance between items remains unexplained by the model. A signiﬁ-
cant chi-square (e.g. P < 0.05) indicates a bad model ﬁt. The RMSEA
is a ﬁt measure based on population error of approximation because it
is difﬁcult to assume that the model will hold exactly for the popu-
lation. Therefore, the RMSEA takes into account the error of approxi-
mation in the population. An RMSEA value <0.05 indicates a close ﬁt
and values up to 0.08 represent reasonable errors of approximation in
the population.
The GFI and AGFI assess the extent to which the model provides a
better ﬁt compared to no model at all. These indices have a range
between 0 and 1, with higher values indicating a better ﬁt. A GFI >0.90
and an AGFI >0.85 indicate a good ﬁt of the model. The CFI is an incre-
mental ﬁt index [47] and represents the proportionate improvement in a
model ﬁt by comparing the target model with a baseline model (usually,
a null model in which all the observed variables are uncorrelated).
The CFI ranges between 0 and 1, with values >0.90 indicating an ade-
quate ﬁt.
The CAIC is a goodness-of-ﬁt measure that adjusts the model’s
chi-square to penalize for model complexity and sample size. This
measure can be used to compare non-hierarchical as hierarchical
(nested) models. Lower values on the CAIC measure indicate
better ﬁt.
Results
Participants
The nurses of the Nephrology team invited 170 patients
to participate in the study. Using a thick-box system, it was
ensured that every patient was only invited once; 155
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patients agreed to take the questionnaires home. The main
reasons for not taking part in the study were the following:
workload because of the amount of questions, resistance
due to the psychological aspect of the study, and patients
believing that questions may be too difﬁcult to answer
without help. Between January 2009 and December 2010,
105 questionnaires were returned. Six patients did not ﬁll
out the questionnaires sufﬁciently, resulting in a sample of
99 patients (30 women and 69 men) with a mean duration
of CKD of 10.81 years. Most patients (65) were married.
With regard to the education level, our sample consisted of
73 patients who ﬁnished secondary school, 20 were college
graduates and 6 were university graduates. Of the 99
patients, 26 were employed, 37 were retired and 18 were
on sick leave and dependent on health insurance.
According to the classiﬁcation of CKD severity, based
on eGFR by MDRD equation, our sample showed mean
eGFR by MDRD 34.5 mL/min (SD 21.66), corresponding to
Phase 3b (Phase 1: >90, Phase 2: 80–89, Phase 3a: 45–59,
Phase 3b: 30–45, Phase 4: 15–29 and Phase 5: <15).
Disease-relevant laboratory characteristics data were
collected from patients’ electronic medical ﬁles and are
presented in Table 1.
Co-morbidity in our sample consisted of: arterial hyper-
tension (n = 54), diabetes mellitus (n = 30), cardiovascular
disease (n = 27), glomerulonephritis (n = 13), polycystic
kidney disease (n = 11), CVA (n = 5) and other diseases
(n = 76). Thirty-four of our patients were on haemodialy-
sis at the time of measurement.
Main results
Correlation analyses. Table 2 provides the Pearson corre-
lations amongst the variables. Acceptance was positively
correlated with MHQL (r = 0.56, P < 0.01) and positively
correlated with PHQL (r = 0.45, P < 0.01). Neuroticism
showed negative correlations with acceptance (r =−0.49,
P < 0.01) and with MHQL (r =−0.52, P < 0.01) (Table 2).
Multiple regression analysis. In our ﬁrst regression ana-
lyses, the unique role of acceptance in explaining physical
well-being (PHQL as dependent variable) was investi-
gated. Results can be summarized as follows. Age and
gender did not contribute in predicting PHQL. From the
disease and co-morbidity variables that were entered step-
wise, only arterial hypertension did signiﬁcantly contrib-
ute in PHQL [β =−0.23, P < 0.05; Fchange(1,91) = 4.780,
P < 0.003, R2change = 0.05]. However, arterial hyperten-
sion was no longer signiﬁcant in the ﬁnal model, when
acceptance and the personality characteristics were
entered. Acceptance accounted for an additional variance
of 18% in PHQL [β = 0.43, P < 0.001; Fchange(1,90) =
21.68, P < 0.001, R2change = 0.18]. The ﬁnal model ex-
plained 23% of variance in the PHQL scores [adjusted R2
= 0.23, F(4.90) = 7.945, P < 0.001].
Table 1. Descriptive statistics: laboratory characteristics
Analyse (unit) N Minimum Maximum Mean SD
Total protein (g/dL) 97 3.60 9.40 6.93 0.74
Albumin (g/dL) 69 2.30 4.90 4.05 0.48
Phosphorus (mg/dL) 98 1.64 7.70 3.57 0.92
Cholesterol (mg/dL) 86 106.00 290.00 187.37 41.08
HbA1c (%) 48 4.80 11.80 6.35 1.41
Haemoglobin (g/dL) 99 8.10 15.90 12.35 1.69
C-reactive protein (mg/dL) 99 0.03 6.50 0.64 0.93
Creatinine (mg/dL) 99 0.62 14.53 3.06 2.77
eGFR by MDRD (mL/min) 99 3.60 103.50 34.49 21.66
Table 2. Means, SD, Cronbach’s alphas and Pearson correlations
Serial no. Variable Means
(SD)
Cronbach alpha 2 3 4 5 6 7 8 9 10 11
1 Age 56.48 (14.26) −0.08 −0.08 0.13 −0.15 −0.12 −0.02 0.01 −0.11 −0.09 −0.02
2 Severity (eGFR by MDRD) 34.49 (21.66) 0.35b 0.08 0.09 0.13 −0.04 0.15 0.02 0.03 −0.04
3 Duration 10.75 (12.60) 0.18 −0.01 0.19 −0.09 0.04 −0.21a 0.18 0.11
4 Acceptance (ICQ) 16.84 (4.11) 0.88 0.34b 0.19 −0.05 0.28b −0.49b 0.45b 0.56b
5 Extraversion (NEO-FFI) 38.95 (6.79) 0.76 0.17 0.14 0.56b −0.37b 0.19 0.32b
6 Openness (NEO-FFI) 34.34 (6.12) 0.63 0.16 0.09 −0.09 0.19 0.18
7 Agreeableness (NEO-FFI) 43.94 (6.33) 0.75 0.35b 0.06 −0.03 0.01
8 Conscientiousness (NEO-FFI) 44.03 (6.40) 0.75 −0.32b 0.20a 0.18
9 Neuroticism (NEO-FFI) 31.35 (7.45) 0.76 −0.24a −0.52b
10 PHQL (SF-36) 52.43 (22.28) 0.88 0.69b
11 MHQL (SF-36) 65.90 (20.32) 0.87
aCorrelation is signiﬁcant at the 0.05 level (two-tailed).
bCorrelation is signiﬁcant at the 0.01 level (two-tailed).
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The second regression analysis with MHQL as a depen-
dent variable showed that both acceptance and neuroticism
have a signiﬁcant contribution in explaining MHQL, 31%
of the variance was additionally explained by acceptance
[β = 0.41, P < 0.001, Fchange(1,91) = 42.43, P < 0.001,
R2change = 0.31]. Neuroticism accounted for an additional
variance of 8% in MHQL, [β =−0.33, P < 0.005, Fchange
(1,90) = 12.16, P < 0.001, R2change = 0.08]. For MHQL,
38% of variance was explained by the ﬁnal model [ad-
justed R2 = 0.38, F (4.90) = 15.55, P < 0.001].
The third regression analysis with acceptance as depen-
dent variable shows that neuroticism has a signiﬁcant con-
tribution to acceptance and accounted for 24% additional
variance in acceptance [β =−0.49, P < 0.001, Fchange
(1,97) = 30.64, P < 0.001, R2change = 0.24], the ﬁnal
model explained 23% of the variance of acceptance [ad-
justed R2 = 0.23, F (1.97) = 30.64, P < 0.001].
For these regression analyses, there were no problems
as regards normality (the kurtosis of the residuals was not
signiﬁcantly different from zero), variance constancy or
curvature. The Variance Inﬂation Factors did not indicate
collinearity problems.
Path analysis (structural equation model). The critical
ratio −0.99 given for the multivariate kurtosis by AMOS
was not signiﬁcant at the 5% level, showing that the
maximum likelihood algorithm was appropriate to carry
out the estimation and testing.
The model showed that acceptance and neuroticism are
signiﬁcant predictors of MHQL, they explain 61% of the
variance. Neuroticism is directly and negatively related to
MHQL and indirectly by the mediation of acceptance;
37% of the total effect of neuroticism on MHQL was
mediated by acceptance. Neuroticism explained 24% of
the variance of acceptance (Figure 1).
Discussion
The objectives of our study were (i) to examine if accep-
tance is positively associated with PHQL and MHQL in
patients with CKD and (ii) whether personality character-
istics inﬂuence acceptance and PHQL and MHQL even
after controlling for some putative confounding variables
and if neuroticism has a negative effect on acceptance
and MHQL.
Results of the ﬁrst aim of our study revealed that accep-
tance was predictive of a better PHQL and MHQL in our
sample of patients with CKD. Adaptive coping is con-
sidered essential in improving HQL, which is an impor-
tant outcome in the care of patients with CKD. Research
shows that a poor HQL signiﬁcantly correlates with less
compliance and increased risks of mortality in end-stage
CKD patients, irrespective of kidney function [2, 4, 48].
Disability due to CKD is linked to a low HQL and
depression in CKD populations [6, 11, 13, 16]. As de-
pression and low HQL are linked to the absence of appro-
priate coping behaviour, it is important to focus also on
adequate coping strategies in this population [21, 49]. The
results of our study indicate that a better HQL might be
achieved by training patients with CKD to adopt a more
‘accepting accommodative coping’, in order to adjust to the
difﬁculties and impairment of their chronic disease.
The second aim of our study was to explore the inﬂu-
ence of personality characteristics on acceptance and
health quality of life. A previous study in CKD has
already highlighted the idea of considering personality to
better understand the adjustment process [50]. In this
study, more neurotic personality characteristics were
associated with less acceptance, both related to MHQL.
Considering possible putative confounding variables,
age, gender, severity and duration of disease seem to have
no impact on these results, only arterial hypertension as
most frequent co-morbidity seemed to have a slight inﬂu-
ence on PHQL. In our sample, 54 of the 99 patients had
arterial hypertension. The fact that arterial hypertension
had a relation with PHQL is in line with clinical practice:
a lot of CKD patients struggle with arterial hypertension
and although there is no great disability, they have to take
daily medication and therefore they feel sick.
Our results show that neuroticism is inversely associated
with acceptance and MHQL in CKD. This emphasizes the
need for psychological assessment with extra attention for
acceptance and personality characteristics at an early stage
of the multidisciplinary treatment of CKD patients in order
to recognize and treat these psychological aspects because
of its impact on MHQL and on future treatment regimes.
Neuroticism is a personality characteristic (characteristic
patterns of thinking, feeling and behaviour) deﬁned as ‘a
person’s level of distress over a period of time, associated
with greater symptom awareness and a vulnerability to
experience negative emotions’ [51, 52]. The association
between neuroticism and coping is thought to be reciprocal,
with an independent inﬂuence of both on physical and
mental health quality of life [34, 47, 53]. As the higher
levels of neuroticism are associated with inﬂexibility, with-
drawal, passivity, wishful thinking, negative emotion focus,
mental disorders and less adaptive coping [54, 55], it is not
Fig. 1. Path analysis. Goodness-of-ﬁt values: χ2 = 2.34 (df = 4), not
signiﬁcant (n.s.): P = 0.67, GFI = 0.99, AGFI = 0.96, CFI = 1, RMSEA =
0.00, CAIC = 63.43. All ﬁt values are acceptable. Standardized β
coefﬁcients (all regression coefﬁcients are signiﬁcant) and R2 values are
shown, with R2 values shown above each variable.
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unexpected that a higher degree of neuroticism is nega-
tively associated with acceptance. Acceptance is described
as ‘a central concept in an accommodative coping strategy’
and is indispensable in adjusting life goals as a response to
an unchangeable event [19]. CKD is a complex progressive
disease. A patient with CKD is faced with constant adjust-
ments to changes in medication, treatment strategies and
role patterns with increasing dependence on medical equip-
ment and on his/her environment. Such a patient therefore
needs an individualized prescription of treatment by a
specialist. This prescription is often different to prescrip-
tions for other patients, who have, according to the view of
the patient, a similar disease. Furthermore, treatment can
change substantially from one extreme to another during
the course of their disease, either because the disease pro-
gresses or because of other factors. Adjusting well to these
changing treatment protocols assumes acceptance of the
disease and ﬂexibility in reorganizing their lives. The
results of our study imply that patients, who are more neu-
rotic, might experience more difﬁculties with acceptance.
This suggests that difﬁculties in coping with the disease
might not only be due to the different adjustment tasks
associated with the type of the disease but are also inﬂu-
enced by personality characteristics.
The ﬁnding that neurotic personality characteristics not
only inﬂuence acceptance (accommodative coping style)
but also the MHQL of CKD patients can be explained by
the relationship between neuroticism and the perception of
health; lower neuroticism being associated with the percep-
tion of better health [40, 56]. Similarly, a recent study in
CKD patients after transplantation [57] shows that lower
neuroticism is associated with a higher PHQL and MHQL.
Our study has some limitations. Most importantly, as
this study was cross-sectional, it cannot determine causal-
ity. It is possible that as a consequence of a good mental
health quality of life, patients are using the ‘accepting
coping strategy’ more and have a lower neurotic score. It
may therefore be worthwhile to determine if psychological
interventions can train people to use an accepting coping
strategy, which results in changes in mental quality of life.
A further limitation was that our sample size was relatively
small and consisted nearly completely of Caucasians from a
single region. As such, we must be cautious in generalizing
the results. Our sample size is comparable with studies on
HQL where different subscales have been used.
The strength of this study and its main clinical contri-
bution lie in the demonstration of the impact of psycho-
logical variables on HQL in CKD patients. This ﬁnding
underlines the value of a psychological assessment in the
care of these patients [58]. A more thorough psychologi-
cal assessment of these variables may lead to a speciﬁc
approach and interventions to improve patient’s quality of
life, which may consequently lead to better medical out-
comes and reduced hospitalization [2–4, 58].
For this population, the perceived support of their ne-
phrologist is an important predictor for patient’s compli-
ance and outcome [59] and a more holistic approach by
nephrologists may help the most appropriate choice of
treatment to be made.
Research that contributes to a better understanding of
the psychological determinants of HQL in CKD can have
important clinical implications because it can initiate an
alternative approach to these patients by nephrologists,
speciﬁc psychological interventions and other supporting
public health services. More studies are needed on which
speciﬁc interventions are effective in improving accep-
tance and HQL in this population.
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